Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calecim
- Development stage
- Preclinical
- Lead developer
- CellResearch
- Modality
- Stem Cell Therapies → Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
Calecim is a line of regenerative cosmeceutical products whose active ingredient is the conditioned media derived from Red Deer Umbilical Cord Lining Mesenchymal Stem Cells (RD-CLMSC). Developed by CellResearch Corporation, this extract is a complex protein mix containing an exosomal suspension rich in cytokines, growth factors, extracellular matrix proteins, and peptides. The product is designed to stimulate human dermal fibroblast (HDF) proliferation and upregulate the production of essential skin components such as elastin and hyaluronic acid. Clinically, Calecim has demonstrated efficacy in improving skin turgor, elasticity, and tone for facial and eyelid rejuvenation, and it has been utilized as a therapeutic intervention for telogen effluvium, including hair loss induced by COVID-19.
- Brand names
- CALECIM Professional Multi-Action CreamCALECIM Professional SerumCALECIM Professional Restorative Hair Complex
- Other names
- RD-CLMSC-CMRed Deer Umbilical Cord Lining Mesenchymal Stem Cell Conditioned MediaRed deer mesenchymal stem cell extractRed deer umbilical cord lining mesenchymal stem cell-conditioned media
Beyond the preview
Go deeper on Calecim.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calecim.